Ikarian Capital, LLC - 30 Nov 2025 SCHEDULE 13G Report for Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX)

Filing Manager
Ikarian Capital, LLC
Reporting Manager
Ikarian Capital, LLC
Security
Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share
Symbol
QNRX
Shares outstanding
839,437 shares
Disclosed Ownership
211,538 shares
Ownership
25%
Form type
SCHEDULE 13G
Filing time
15 Dec 2025, 21:53:07 UTC
Date of event
30 Nov 2025
Next filing
06 Feb 2026
SEC
View on sec.gov

Quoteable Key Fact

"Ikarian Capital, LLC disclosed 25% ownership in Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX) on 30 Nov 2025."

Quick Takeaways

  • Ikarian Capital, LLC filed SCHEDULE 13G for Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX).
  • Disclosed ownership: 25%.
  • Date of event: 30 Nov 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 Dec 2025, 21:53.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Ikarian Capital, LLC 25% 211,538 0 211,538 /s/ Neil Shahrestani Neil Shahrestani, Sole Manager
Neil Shahrestani 25% 211,538 0 211,538 /s/ Neil Shahrestani Neil Shahrestani
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .